{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T08:45:32Z","timestamp":1785746732186,"version":"3.56.0"},"reference-count":37,"publisher":"Akademiai Kiado Zrt.","issue":"31","license":[{"start":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T00:00:00Z","timestamp":1785628800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.akjournals.com"],"crossmark-restriction":true},"short-container-title":["OH"],"published-print":{"date-parts":[[2026,8,2]]},"abstract":"\n Bevezet\u00e9s:<\/jats:italic>\n Magyarorsz\u00e1gi epidemiol\u00f3giai adatok alapj\u00e1n a\n cardiovascularis betegs\u00e9gek okozz\u00e1k a legnagyobb eg\u00e9szs\u00e9gvesztes\u00e9get a lakoss\u00e1g\n k\u00f6r\u00e9ben, \u00e9s az id\u0151 el\u0151tti hal\u00e1loz\u00e1s jelent\u0151s r\u00e9sz\u00e9\u00e9rt is felel\u0151sek. Ez\n meger\u0151s\u00edti azt az eg\u00e9szs\u00e9gpolitikai \u00e1ll\u00e1spontot, hogy a cardiovascularis\n prevenci\u00f3nak, bele\u00e9rtve a gy\u00f3gyszeres ter\u00e1piah\u0171s\u00e9g jav\u00edt\u00e1s\u00e1t, kiemelt priorit\u00e1st\n kell kapnia a betegell\u00e1t\u00e1sban. Az akut coronaria szindr\u00f3m\u00e1n \u00e1tesett betegek\n hossz\u00fa t\u00e1v\u00fa t\u00fal\u00e9l\u00e9se nagym\u00e9rt\u00e9kben f\u00fcgg a gy\u00f3gyszeres ter\u00e1piah\u0171s\u00e9gt\u0151l, k\u00fcl\u00f6n\u00f6sen\n a sztatinok \u00e9s v\u00e9ralvad\u00e1sg\u00e1tl\u00f3k tekintet\u00e9ben, ugyanakkor hazai felm\u00e9r\u00e9sek a\n prevent\u00edv gy\u00f3gyszerek szed\u00e9s\u00e9nek hi\u00e1nyoss\u00e1gaira utalnak.\n C\u00e9lkit\u0171z\u00e9s:<\/jats:italic>\n Vizsg\u00e1latunk c\u00e9lja a percutan\n coronariaintervenci\u00f3n \u00e1tesett m\u00e1sodlagos prevenci\u00f3s \u00e9s a kontrollcsoportba\n tartoz\u00f3 els\u0151dleges prevenci\u00f3s betegek thrombocytaaggreg\u00e1ci\u00f3-g\u00e1tl\u00f3kkal \u00e9s\n koleszterinszint-cs\u00f6kkent\u0151kkel kapcsolatos hozz\u00e1\u00e1ll\u00e1s\u00e1nak \u00e9s hiedelmeinek\n \u00f6sszehasonl\u00edt\u00e1sa volt a Beliefs about Medicines Questionnaire (BMQ)\n seg\u00edts\u00e9g\u00e9vel.\n M\u00f3dszerek:<\/jats:italic>\n Keresztmetszeti, k\u00e9rd\u0151\u00edves\n vizsg\u00e1latban 162 percutan coronariaintervenci\u00f3n \u00e1tesett m\u00e1sodlagos prevenci\u00f3s \u00e9s\n 136 els\u0151dleges prevenci\u00f3s beteg vett r\u00e9szt. A gy\u00f3gyszerattit\u0171d\u00f6k m\u00e9r\u00e9se a BMQ\n speci\u00e1lis \u00e9s \u00e1ltal\u00e1nos dimenzi\u00f3i ment\u00e9n t\u00f6rt\u00e9nt, a statisztikai elemz\u00e9shez az\n SPSS 27.0 programcsomagot alkalmaztunk.\n Eredm\u00e9nyek:<\/jats:italic>\n A\n m\u00e1sodlagos prevenci\u00f3s betegek eset\u00e9ben elmondhat\u00f3, hogy mindk\u00e9t gy\u00f3gyszercsoport\n eset\u00e9ben kisebb aggodalomszint \u00e9s elfogad\u00f3bb hozz\u00e1\u00e1ll\u00e1s volt jellemz\u0151, m\u00edg az\n els\u0151dleges prevenci\u00f3s csoportban gyakoribb volt a szkeptikus (p<0,05) \u00e9s az\n ambivalens hozz\u00e1\u00e1ll\u00e1s (p<0,001). A v\u00e1laszad\u00f3k attit\u0171dcsoportok szerinti\n elemz\u00e9se, valamint a BMQ \u00e1ltal\u00e1nos alsk\u00e1l\u00e1inak vizsg\u00e1lata alapj\u00e1n a percutan\n coronariaintervenci\u00f3hoz t\u00e1rsul\u00f3an szignifik\u00e1ns k\u00fcl\u00f6nbs\u00e9gek voltak megfigyelhet\u0151k\n a gy\u00f3gyszerekkel kapcsolatos hiedelmeket illet\u0151en. Ez a v\u00e1ltoz\u00e1s a gy\u00f3gyszeres\n ter\u00e1piah\u0171s\u00e9ggel \u00f6sszef\u00fcgg\u0151 attit\u0171d\u00f6k szempontj\u00e1b\u00f3l jelent\u0151s volt (p<0,001).\n Megbesz\u00e9l\u00e9s \u00e9s k\u00f6vetkeztet\u00e9s:<\/jats:italic>\n A percutan\n coronariaintervenci\u00f3n \u00e1tesett betegek kedvez\u0151bb gy\u00f3gyszerattit\u0171d\u00f6kkel\n rendelkeznek, ami kiemeli a c\u00e9lzott eduk\u00e1ci\u00f3 \u00e9s pszichoeduk\u00e1ci\u00f3 szerep\u00e9t a nem\n intervenci\u00f3n \u00e1tesett popul\u00e1ci\u00f3 ter\u00e1piah\u0171s\u00e9g\u00e9nek jav\u00edt\u00e1s\u00e1ban. Ugyanakkor a\n ter\u00e1piah\u0171s\u00e9g a m\u00e1sodlagos prevenci\u00f3s csoportban sem tekinthet\u0151 optim\u00e1lisnak,\n ez\u00e9rt ebben a csoportban is indokolt a tov\u00e1bbi c\u00e9lzott betegoktat\u00e1s alkalmaz\u00e1sa.\n Orv Hetil. 2026; 167(31): 1238\u20131247.\n <\/jats:p>","DOI":"10.1556\/650.2026.33612","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T06:51:32Z","timestamp":1785739892000},"page":"1238-1247","update-policy":"https:\/\/doi.org\/10.1556\/policypage.crossmark.crossref.2","source":"Crossref","is-referenced-by-count":0,"title":["A sztatin- \u00e9s thrombocytaaggreg\u00e1ci\u00f3-g\u00e1tl\u00f3 kezel\u00e9s ter\u00e1piah\u0171s\u00e9g\u00e9nek \u00f6sszehasonl\u00edt\u00e1sa els\u0151dleges \u00e9s m\u00e1sodlagos cardiovascularis prevenci\u00f3s betegekben"],"prefix":"10.1556","volume":"167","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1476-6407","authenticated-orcid":true,"given":"Rita","family":"Szendrei-L\u00f3di","sequence":"first","affiliation":[{"name":"B\u00e9k\u00e9s V\u00e1rmegyei K\u00f6zponti K\u00f3rh\u00e1z, P\u00e1ndy K\u00e1lm\u00e1n Tagk\u00f3rh\u00e1z, Kardiol\u00f3giai Oszt\u00e1ly Gyula, Szent Istv\u00e1n u. 17\u201319., 5700 Magyarorsz\u00e1g"},{"name":"G\u00e1l Ferenc Egyetem, Eg\u00e9szs\u00e9g- \u00e9s Szoci\u00e1lis Tudom\u00e1nyi Kar, \u00c1pol\u00e1studom\u00e1nyi Tansz\u00e9k Gyula Magyarorsz\u00e1g"},{"name":"P\u00e9csi Tudom\u00e1nyegyetem, Eg\u00e9szs\u00e9gtudom\u00e1nyi Doktori Iskola P\u00e9cs Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"T\u00f6m\u0151","sequence":"additional","affiliation":[{"name":"G\u00e1l Ferenc Egyetem, Eg\u00e9szs\u00e9g- \u00e9s Szoci\u00e1lis Tudom\u00e1nyi Kar, \u00c1pol\u00e1studom\u00e1nyi Tansz\u00e9k Gyula Magyarorsz\u00e1g"},{"name":"P\u00e9csi Tudom\u00e1nyegyetem, Eg\u00e9szs\u00e9gtudom\u00e1nyi Doktori Iskola P\u00e9cs Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szilvia","family":"Beke","sequence":"additional","affiliation":[{"name":"G\u00e1l Ferenc Egyetem, Eg\u00e9szs\u00e9g- \u00e9s Szoci\u00e1lis Tudom\u00e1nyi Kar, \u00c1pol\u00e1studom\u00e1nyi Tansz\u00e9k Gyula Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"M\u00e1rk","sequence":"additional","affiliation":[{"name":"B\u00e9k\u00e9s V\u00e1rmegyei K\u00f6zponti K\u00f3rh\u00e1z, P\u00e1ndy K\u00e1lm\u00e1n Tagk\u00f3rh\u00e1z, Kardiol\u00f3giai Oszt\u00e1ly Gyula, Szent Istv\u00e1n u. 17\u201319., 5700 Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"425","reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"Kov\u00e1cs B, Szap\u00e1ry L, S\u00e1ntics-Kajos LF, et al. Ischemic stroke in\n Europe: incidence trends over three decades (1991-2021). [Ischaemi\u00e1s stroke\n Eur\u00f3p\u00e1ban: incidenciatrendek h\u00e1rom \u00e9vtized t\u00e1vlat\u00e1ban (1991-2021).] Orv Hetil.\n 2025; 166: 1642-1652. [Hungarian]\n https:\/\/doi.org\/10.1556\/650.2025.33406","DOI":"10.1556\/650.2025.33406"},{"key":"R2","unstructured":"European Commission, Eurostat. 1.1 million deaths linked to\n avoidable conditions. Available from:\n https:\/\/ec.europa.eu\/eurostat\/web\/products-eurostat-news\/w\/ddn-20250630-1?utm\n [accessed: February 20, 2026]."},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Vitrai J, Horv\u00e1th V. What diseases and risks cause health losses in\n Hungary? [Milyen betegs\u00e9gek \u00e9s kock\u00e1zatok okozz\u00e1k a magyarorsz\u00e1gi\n eg\u00e9szs\u00e9gvesztes\u00e9geket?] Orv Hetil. 2026; 167: 232-242. [Hungarian]\n https:\/\/doi.org\/10.1556\/650.2026.33481","DOI":"10.1556\/650.2026.33481"},{"key":"R4","unstructured":"European Society of Cardiology. Euroheart European unified\n registries for heart care evaluation and randomised trials. Available from:\n https:\/\/www.escardio.org\/data-science\/data-collection\/patient-registries-and-observational-data-new\/euroheart\/\n [accessed: February 22, 2026]."},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for\n describing and defining adherence to medications. Br J Clin Pharmacol. 2012; 73:\n 691-705.\n https:\/\/doi.org\/10.1111\/j.1365-2125.2012.04167.x","DOI":"10.1111\/j.1365-2125.2012.04167.x"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Tomcs\u00e1nyi J. Adherence to statins in patients with myocardial\n infarction in Hungary. [Statin gy\u00f3gyszerszed\u00e9si gyakorlat myocardialis infarctus\n ut\u00e1n Magyarorsz\u00e1gon.] Orv Hetil. 2017; 158: 443-446. Erratum: 2017; 158: 839.\n [Hungarian] https:\/\/doi.org\/10.1556\/650.2017.30687","DOI":"10.1556\/650.2017.30687"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Simonyi G, Ferenci T, Finta E, et al. Five-year persistence of\n statins after acute myocardial infarction in statin-na\u00efve patients. [\u00d6t\u00e9ves\n sztatinperzisztencia akut myocardialis infarktus ut\u00e1n, kor\u00e1bban sztatint nem\n szed\u0151kben.] Orv Hetil. 2024; 165: 171-176. [Hungarian]\n https:\/\/doi.org\/10.1556\/650.2024.32966","DOI":"10.1556\/650.2024.32966"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"M\u00e1rk L, Nagy VL, Hanyecz V, et al. Temporal changes in serum total\n cholesterol levels during a 30-year follow-up in a South-Hungarian village\n population. [A sz\u00e9rum-\u00f6sszkoleszterinszint id\u0151beli v\u00e1ltoz\u00e1sa egy d\u00e9l-alf\u00f6ldi\n telep\u00fcl\u00e9s lakoss\u00e1g\u00e1ban 30 \u00e9ves k\u00f6vet\u00e9s sor\u00e1n.] Orv Hetil. 2026; 167: 9-15.\n [Hungarian] https:\/\/doi.org\/10.1556\/650.2026.33445","DOI":"10.1556\/650.2026.33445"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"Horne R, Chapman SC, Parham R, et al. Understanding patients\u2019\n adherence-related beliefs about medicines prescribed for long-term conditions: a\n meta-analytic review of the necessity-concerns framework. PLOS ONE 2013; 8:\n e80633. https:\/\/doi.org\/10.1371\/journal.pone.0080633","DOI":"10.1371\/journal.pone.0080633"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Foot H, La Caze A, Gujral G, et al. The necessity-concerns framework\n predicts adherence to medication in multiple illness conditions: a\n meta-analysis. Patient Educ Couns. 2016; 99: 706-717.\n https:\/\/doi.org\/10.1016\/j.pec.2015.11.004","DOI":"10.1016\/j.pec.2015.11.004"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Chow CK, Jolly S, Rao-Melacini P, et al. Association of diet,\n exercise, and smoking modification with risk of early cardiovascular events\n after acute coronary syndromes. Circulation 2010; 121: 750-758.\n https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.891523","DOI":"10.1161\/CIRCULATIONAHA.109.891523"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Visseren FL, Mach F, Smulders YM, et al. 2021 ESC Guidelines on\n cardiovascular disease prevention in clinical practice: developed by the task\n force for cardiovascular disease prevention in clinical practice with\n representatives of the European Society of Cardiology and 12 medical societies\n with the special contribution of the European Association of Preventive\n Cardiology (EAPC). Eur Heart J. 2021; 42: 3227-3337. Erratum: Eur Heart J. 2022;\n 43: 4468. https:\/\/doi.org\/10.1093\/eurheartj\/ehac458","DOI":"10.1093\/eurheartj\/ehac458"},{"key":"R13","doi-asserted-by":"crossref","unstructured":"Mach F, Baigent C, Catapano AL, et al. 2019 ESC\/EAS Guidelines for\n the management of dyslipidaemias: lipid modification to reduce cardiovascular\n risk: the Task Force for the management of dyslipidaemias of the European\n Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur\n Heart J. 2020; 41: 111-188. Erratum: Eur Heart J. 2020; 41: 4255.\n https:\/\/doi.org\/10.1093\/eurheartj\/ehz826","DOI":"10.1093\/eurheartj\/ehz826"},{"key":"R14","doi-asserted-by":"crossref","unstructured":"Mach F, Koskinas KC, Roeters van Lennep JE, et al. 2025 focused\n update of the 2019 ESC\/EAS Guidelines for the management of dyslipidaemias:\n developed by the task force for the management of dyslipidaemias of the European\n Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur\n Heart J. 2025; 46: 4359-4378. Erratum: Eur Heart J. 2026; 47: 697.\n https:\/\/doi.org\/10.1093\/eurheartj\/ehaf1036","DOI":"10.1093\/eurheartj\/ehaf1036"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"J\u00e1nosi A, Ofner P, Kiss Z, et al. Adherence to medication after\n myocardial infarction and its impact on outcome: a registry-based analysis from\n the hungarian myocardial infarction registry. [Sz\u00edvinfarktust t\u00fal\u00e9lt betegek\n ter\u00e1piah\u0171s\u00e9ge a m\u00e1sodlagos megel\u0151z\u00e9s szempontj\u00e1b\u00f3l fontos gy\u00f3gyszeres\n kezel\u00e9sekhez.] Orv Hetil. 2017; 158: 1051-1057. [Hungarian]\n https:\/\/doi.org\/10.1556\/650.2017.30795","DOI":"10.1556\/650.2017.30795"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Nagy GG, M\u00e1rk L, Gerencs\u00e9r A, et al. A nation-wide evaluation of\n suboptimal lipid-lowering treatment patterns among patients undergoing\n intervention for acute coronary syndrome in Hungary. J Clin Med. 2024; 13: 6562.\n https:\/\/doi.org\/10.3390\/jcm13216562","DOI":"10.3390\/jcm13216562"},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Bradley CK, Wang TY, Li S, et al. Patient-reported reasons for\n declining or discontinuing statin therapy: insights from the PALM registry. J Am\n Heart Assoc. 2019; 8: e011765.\n https:\/\/doi.org\/10.1161\/JAHA.118.011765","DOI":"10.1161\/JAHA.118.011765"},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Mori Y, Friede T, Hattori S, et al. Impact of nonadherence to any\n antiplatelet therapy after PCI with drug-eluting stents on critical outcomes.\n JACC Asia 2025; 5: 758-768.\n https:\/\/doi.org\/10.1016\/j.jacasi.2025.03.008","DOI":"10.1016\/j.jacasi.2025.03.008"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Luu NM, Dinh AT, Nguyen TT, et al. Adherence to antiplatelet therapy\n after coronary intervention among patients with myocardial infarction attending\n Vietnam National Heart Institute. Biomed Res Int. 2019; 2019: 6585040.\n https:\/\/doi.org\/10.1155\/2019\/6585040","DOI":"10.1155\/2019\/6585040"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"M\u00e1rk L, Gutman N, Vitrai J. Potential cardiovascular benefit of\n optimized lipid-lowering and antiplatelet therapy in patients with acute\n coronary syndrome - a simulation analysis. [Optimaliz\u00e1lt lipidcs\u00f6kkent\u00e9ssel \u00e9s\n thrombocytaaggreg\u00e1ci\u00f3-g\u00e1tl\u00f3 kezel\u00e9ssel el\u00e9rhet\u0151 potenci\u00e1lis cardiovascularis\n nyeres\u00e9g akut coronaria szindr\u00f3m\u00e1n \u00e1tesett betegekben - szimul\u00e1ci\u00f3s elemz\u00e9s.]\n Orv Hetil. 2024; 165: 1746-1752. [Hungarian]\n https:\/\/doi.org\/10.1556\/650.2024.33126","DOI":"10.1556\/650.2024.33126"},{"key":"R21","doi-asserted-by":"crossref","unstructured":"Kronish IM, Rieckmann N, Burg MM, et al. The psychosocial context\n impacts medication adherence after acute coronary syndrome. Ann Behav Med. 2014;\n 47: 158-164.\n https:\/\/doi.org\/10.1007\/s12160-013-9544-0","DOI":"10.1007\/s12160-013-9544-0"},{"key":"R22","doi-asserted-by":"crossref","unstructured":"Barry AR, Wang EH, Chua D, et al. Patients\u2019 beliefs about their\n cardiovascular medications after acute coronary syndrome: a prospective\n observational study. CJC Open 2023; 5: 745-753.\n https:\/\/doi.org\/10.1016\/j.cjco.2023.07.004","DOI":"10.1016\/j.cjco.2023.07.004"},{"key":"R23","doi-asserted-by":"crossref","unstructured":"Basios A, Markozannes G, Ntzani EE, et al. Prevalence and\n determinants of adherence to statin therapy: a systematic review and\n meta-analysis. Eur J Prev Cardiol. 2025 Dec 16: zwaf769. Doi:\n 10.1093\/eurjpc\/zwaf769. [Online ahead of print]\n https:\/\/doi.org\/10.1093\/eurjpc\/zwaf769","DOI":"10.1093\/eurjpc\/zwaf769"},{"key":"R24","doi-asserted-by":"crossref","unstructured":"Li H, Jia X, Min H, et al. Relationships between beliefs about\n statins and non-adherence in inpatients from Northwestern China: a\n cross-sectional survey. Front Pharmacol. 2023; 14: 1078215.\n https:\/\/doi.org\/10.3389\/fphar.2023.1078215","DOI":"10.3389\/fphar.2023.1078215"},{"key":"R25","doi-asserted-by":"crossref","unstructured":"B\u00edr\u00f3 \u00c9, Szab\u00f3 P, K\u00f3sa K. Health literacy of the Hungarian adult\n population. [A magyar feln\u0151tt lakoss\u00e1g eg\u00e9szs\u00e9gm\u0171velts\u00e9ge.] Eg\u00e9szs\u00e9gfejleszt\u00e9s\n 2022; 63: 3-11. [Hungarian]\n https:\/\/doi.org\/10.24365\/ef.8496","DOI":"10.24365\/ef.8496"},{"key":"R26","unstructured":"B\u00edr\u00f3 \u00c9, Vincze F, M\u00e1ty\u00e1s G, et al. Health Literacy among the adult\n population in Hungary: findings from an international study. [A magyar feln\u0151tt\n lakoss\u00e1g eg\u00e9szs\u00e9gm\u0171velts\u00e9ge egy nemzetk\u00f6zi kutat\u00e1s t\u00fckr\u00e9ben.] N\u00e9peg\u00e9szs\u00e9g\u00fcgy\n 2021; 98: 275. [Hungarian]"},{"key":"R27","unstructured":"Boruzs K, Juh\u00e1sz A, Nagy Cs, et al. Relationship between statin\n utilization and socioeconomic deprivation in Hungary. [A sztatin haszn\u00e1lat \u00e9s a\n t\u00e1rsadalmi-gazdas\u00e1gi st\u00e1tusz kapcsolata Magyarorsz\u00e1gon.] N\u00e9peg\u00e9szs\u00e9g\u00fcgy 2018;\n 95: 59-68. [Hungarian]"},{"key":"R28","doi-asserted-by":"crossref","unstructured":"Horne R, Weinman J, Hankins M. The beliefs about medicines\n questionnaire: the development and evaluation of a new method for assessing the\n cognitive representation of medication. Psychology Health 1999; 14: 1-24.\n https:\/\/doi.org\/10.1080\/08870449908407311","DOI":"10.1080\/08870449908407311"},{"key":"R29","doi-asserted-by":"crossref","unstructured":"Boruzs K, Fekete Z, Dombr\u00e1di V, et al. Differences in beliefs about\n cholesterol-lowering medications among the Visegrad group countries: a\n cross-sectional study. Front Public Health 2021; 9: 645043.\n https:\/\/doi.org\/10.3389\/fpubh.2021.645043","DOI":"10.3389\/fpubh.2021.645043"},{"key":"R30","doi-asserted-by":"crossref","unstructured":"Horne R, Weinman J. Self-regulation and self-management in asthma:\n exploring the role of illness perceptions and treatment beliefs in explaining\n non-adherence to preventer medication. Psychology Health 2002; 17: 17-32.\n https:\/\/doi.org\/10.1080\/08870440290001502","DOI":"10.1080\/08870440290001502"},{"key":"R31","doi-asserted-by":"crossref","unstructured":"Lowenstern A, Navar AM, Li S, et al. Association of clinician\n knowledge and statin beliefs with statin therapy use and lipid levels (a survey\n of US practice in the PALM Registry). Am J Cardiol. 2019; 123: 1011-1018.\n https:\/\/doi.org\/10.1016\/j.amjcard.2018.12.031","DOI":"10.1016\/j.amjcard.2018.12.031"},{"key":"R32","doi-asserted-by":"crossref","unstructured":"Huiskes VJ, van den Ende CH, van Dijk L, et al. Association between\n healthcare practitioners\u2019 beliefs about statins and patients\u2019 beliefs and\n adherence. Br J Clin Pharmacol. 2021; 87: 1082-1088.\n https:\/\/doi.org\/10.1111\/bcp.14467","DOI":"10.1111\/bcp.14467"},{"key":"R33","doi-asserted-by":"crossref","unstructured":"Goldstein KM, Zullig LL, Bastian LA, et al. Statin adherence: does\n gender matter? Curr Atheroscler Rep. 2016; 18: 63.\n https:\/\/doi.org\/10.1007\/s11883-016-0619-9","DOI":"10.1007\/s11883-016-0619-9"},{"key":"R34","doi-asserted-by":"crossref","unstructured":"S\u00e1ri C, Heesch CM, Kov\u00e1cs JA, et al. Participation in a\n comprehensive cardiac rehabilitation program improves mid- and long-term\n prognosis in survivors of acute coronary syndrome. Am J Prev Cardiol. 2025; 23:\n 101042. https:\/\/doi.org\/10.1016\/j.ajpc.2025.101042","DOI":"10.1016\/j.ajpc.2025.101042"},{"key":"R35","doi-asserted-by":"crossref","unstructured":"Vitrai J. Lost working time due to ill health in Hungary in 2021. [A\n megromlott eg\u00e9szs\u00e9g okozta munkaid\u0151-vesztes\u00e9g Magyarorsz\u00e1gon 2021-ben.] Orv\n Hetil. 2024; 165: 2026-2032. [Hungarian]\n https:\/\/doi.org\/10.1556\/650.2024.33205","DOI":"10.1556\/650.2024.33205"},{"key":"R36","doi-asserted-by":"crossref","unstructured":"Yu J, Baber U, Mastoris I, et al. Sex-based differences in cessation\n of dual-antiplatelet therapy following percutaneous coronary intervention with\n stents. JACC Cardiovasc Interv. 2016; 9: 1461-1469.\n https:\/\/doi.org\/10.1016\/j.jcin.2016.04.004","DOI":"10.1016\/j.jcin.2016.04.004"},{"key":"R37","doi-asserted-by":"crossref","unstructured":"J\u00e1nosi A, Csat\u00f3 G, Ferenci T, et al. Emergency care of patients with\n myocardial infarction: from the onset of symptoms until opening the vessel. [A\n sz\u00edvinfarktus miatt kezelt betegek s\u00fcrg\u0151ss\u00e9gi ell\u00e1t\u00e1sa: a panasz kezdet\u00e9t\u0151l az\n \u00e9r megnyit\u00e1s\u00e1ig.] Orv Hetil. 2025; 166: 963-969. [Hungarian]\n https:\/\/doi.org\/10.1556\/650.2025.33315","DOI":"10.1556\/650.2025.33315"}],"container-title":["Orvosi Hetilap"],"original-title":[],"link":[{"URL":"https:\/\/www.akjournals.com\/view\/journals\/650\/167\/31\/article-p1238.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.akjournals.com\/downloadpdf\/journals\/650\/167\/31\/article-p1238.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.akjournals.com\/downloadpdf\/journals\/650\/167\/31\/article-p1238.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T07:57:41Z","timestamp":1785743861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.akjournals.com\/view\/journals\/650\/167\/31\/article-p1238.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,2]]},"references-count":37,"journal-issue":{"issue":"31"},"URL":"https:\/\/doi.org\/10.1556\/650.2026.33612","relation":{},"ISSN":["0030-6002","1788-6120"],"issn-type":[{"value":"0030-6002","type":"print"},{"value":"1788-6120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,2]]}}}